UK Junior Doctors Strike: BMC calls for credible offer to end strike

London: An Indian-origin medic and co-chair of the medical association’s junior doctors’ panel on Wednesday called on the UK government to get around the negotiating table as his colleagues began a six-day strike, the longest in Britain’s health service history. 

Dr Vivek Trivedi, co-chair of the British Medical Association Junior Doctors Committee, told the BBC that ministers must come forward with a credible pay offer so they can call off the strikes.

The National Health Service relies on thousands of junior doctors or qualified medical professionals undergoing their specialist training in hospitals, who have been taking industrial action since last year demanding better pay in line with inflation.

Also Read:Indian-origin doctor’s pandemic rock band gains popularity, has upcoming tour

“Anyone from the government could still come to us today and if we thought that offer was credible, and if we can resume talks and build on that, then we can stop our strike action for the rest of the week,” Trivedi told the BBC.

The talks between junior doctors and the UK government broke down last month as they rejected an offer of a pay rise averaging 3 per cent, on top of an average of nearly 9 per cent junior doctors received in April last year.

The BMA has been asking for an extra 35 per cent to make up for what they say are below-inflation pay rises dating back to 2008.

“We’re not asking for any uplift or pay restoration to happen overnight. We’re not even saying it has to happen in one year. We are very happy to look over deals that would span several years – but what we need to do is to start a way towards that and not further than pay erosion. That 3 per cent pay uplift would still have amounted to pay cuts for many doctors this year,” added Trivedi.

However, UK Health Secretary Victoria Atkins said junior doctors must call off their strike before she can get back to the negotiating table.

“I urge the BMA Junior Doctors Committee to call off their strikes and come back to the negotiating table so we can find a fair and reasonable solution to end the strikes once and for all,” Atkins said in a statement.

“January is typically the busiest time of the year for the NHS and these strikes will have a serious impact on patients across the country. Over 1.2 million appointments have already been rescheduled since industrial action began, including over 88,000 during last month’s strikes. The NHS has again put in place robust contingency plans to protect patient safety and it is vital anyone who needs medical help continues to come forward,” she said.

NHS National Medical Director Professor Sir Stephen Powis also described January as one of the busiest and most challenging times for the health service, as a result of the winter pressures of flu and COVID combined.

“This latest round of strike action will not only have an impact on this week but will have an ongoing effect on the weeks and months ahead, as we struggle to recover services and cope with heavy demand,” said Powis.

NHS England is advising patients in a life-threatening emergency to call 999 and for everything else to use the 111 medical helpline.

Powered by WPeMatico

New Govt guidelines define who is an Intensivist

Releasing the guidelines for Intensive Care Unit Admission and Discharge Criteria, the Ministry of Health and Family Welfare has given a clear-cut definition on who is an “Intensivist” or Critical Care Specialist.

These guidelines, compiled by a total number of 24 experts and released by the Directorate General of Health Services (DGHS) operative under the Union Health Ministry, specified that to be called an “Intensivist”, a specialist needs to have a specific training, certification and experience in managing critically ill patients in an ICU.

For more details, check out the link given below:

New Govt Guidelines Define Who Is An Intensivist

Powered by WPeMatico

Govt releases expert consensus statement on ICU admission and discharge criteria

For the first time, the Union Ministry of Health and Family Welfare has released an Expert Consensus Statement defining patients’ admission and discharge criteria to the Intensive Care Unit (ICU) and other related details.

These guidelines for Intensive Care Unit Admission and Discharge Criteria, compiled by a total number of 24 experts and released by the Directorate General of Health Services (DGHS) operative under the Union Health Ministry, addressed several issues including ICU Admission criteria and specifically it defined the critically ill patients who should not be admitted to the ICU.

For more details, check out the link given below:

GOI Releases Expert Consensus Statement On ICU Admission And Discharge Criteria, Key Takeaways

Powered by WPeMatico

Pfizer gene therapy for bleeding disorder approved in Canada

Canada: Pfizer said on Wednesday that Canada’s health regulator approved its gene therapy for the treatment of a rare inherited bleeding disorder called hemophilia B ahead of a U.S. decision.

The approval was based on late-stage trials that showed a single dose of the therapy, to be sold under the brand name Beqvez, was superior to the current standard of care which involves replacing a blood-clotting protein called factor IX.

The U.S. Food and Drug Administration (FDA) had in November 2022 approved CSL’s Hemgenix, making it the first one-time gene therapy for hemophilia B.

CSL had acquired exclusive global rights to Hemgenix from uniQure NV in 2021.

Pfizer is also seeking U.S. approval for its experimental antibody, marstacimab, to treat hemophilia A and B.

Hemophilia B is found in 1 in 40,000 people and represents about 15% of patients with hemophilia, according to the FDA.

The U.S. health regulator is expected to give its decision on Pfizer’s therapy in the second quarter of 2024.

Read also: CDSCO panel Approves Pfizer’s Protocol Amendment Proposal for Anti-cancer Drug Elranatamab

Powered by WPeMatico

Dr RV Asokan takes charge as National president of Indian Medical Association

Kollam: On a momentous occasion at the 98th national conference of the Indian Medical Association (IMA) held at Kovalam, Dr R.V. Asokan, a distinguished doctor from Kerala, has officially assumed the position of national president of the Indian Medical Association (IMA). Dr Asokan is a practising general physician running a 43 bedded hospital, in Punalur, a small town in Kollam district of Kerala.

Dr. Asokan’s ascendancy to the prestigious position is a testament to his notable contributions and leadership within the medical fraternity. Post MBBS, he completed his MD in General Medicine. He was the IMA state secretary of Kerala state for 3 years and also served as its state president. Having previously served as the IMA national secretary and held key positions at both the state chapter as president and secretary, Dr Asokan brings a wealth of experience and expertise to his new role. His dedicated service at various levels within the IMA underscores a commitment to advancing healthcare initiatives and advocating for the medical community.

Also Read: Hospitals cannot admit critically ill patients in ICU without consent: GOI ICU Admission guidelines

He conceived and established IMAGE which was a project to handle bio-medical waste of the entire Kerala, he was the chairman of the scheme for six years. He also played the lead in bringing the Rs 100 crore GFATM TB public-private mix project to IMA and served as its National coordinator for 6 years. He served for two years in the Strategy and Technical Advisory Group for TB in WHO (Geneva) and is one of the contributors of international standards for TB care. He served as the National Joint Secretary of the IMA Hospital Board of India for 4 years and its chairman for the past 4 years. 

As per a recent media report by The Hindu, the esteemed vice-presidents of IMA accompanying Dr Asokan include Gunasekharan from Tamil Nadu, Shivkumar Utture from Maharashtra, Suresh Gutta from Telangana, and Ashok Sharda from Rajasthan. Anil Kumar Naik, representing Gujarat, has assumed the pivotal role of the national secretary general, overseeing crucial administrative functions. 

The team of joint secretaries includes Munish Prabhakar from Haryana, Prakash Lalchandani from Delhi, M. Venkatachalapathy from Karnataka, and Pradeep Kumar Nemani from West Bengal, contributing to the collaborative leadership structure of the IMA. Shitij Bali, hailing from Delhi, has taken on the role of finance secretary, overseeing the financial affairs of the association.

Powered by WPeMatico

GOI Releases Expert Consensus Statement on ICU Admission and Discharge Criteria, Key Takeaways

New Delhi: For the first time, the Union Ministry of Health and Family Welfare has released an Expert Consensus Statement defining patients’ admission and discharge criteria to the Intensive Care Unit (ICU) and other related details.

These guidelines for Intensive Care Unit Admission and Discharge Criteria, compiled by a total number of 24 experts and released by the Directorate General of Health Services (DGHS) operative under the Union Health Ministry, addressed several issues including ICU Admission criteria and specifically it defined the critically ill patients who should not be admitted to the ICU.

Apart from this, these guidelines also clarified the ICU Discharge criteria, further defining the minimum patients monitoring required while awaiting an ICU bed, the minimum stabilisation required before transferring a patient to ICU, and the minimum monitoring required for transferring a critically ill patient (inter-facility transfer to hospital/ICU).

Referring to the Expert Consensus Statements, the guidelines mentioned, “The Expert Consensus statements have been made using the Delphi methodology to generate consensus. The Steering Group for Delphi process was SNM, RKM and PN who conducted the Delphi surveys using Google forms, prepared the Delphi statements and the reports. The Steering Group did not vote in Delphi surveys. The rest of the Experts voted anonymously over three rounds. Consensus was defined as achieved for an option when voted by 70% or more of the Experts. Stability was checked for all responses. The final statements were drafted from the MCQ responses that achieved consensus and stability.”

Expert Consensus Statement- Seven Things to Remember:

1. First of all, these guidelines clarified that the “Criteria for admitting a patient to ICU should be based on organ failure and need for organ support or in anticipation of deterioration in the medical condition.” 

Other ICU-related details including admission, discharge, patient monitoring, and transfer of patients are as follows:

2. ICU Admission Criteria: 

The guidelines lay down the following admission criteria to the Intensive Care Unit:

 Altered level of consciousness of recent onset

 Hemodynamic instability (e.g., clinical features of shock, arrythmias)

 Need for respiratory support (e.g. escalating oxygen requirement, de–novo respiratory failure requiring non-invasive ventilation, invasive mechanical ventilation, etc.)

 Patients with severe acute (or acute–on–chronic) illness requiring intensive monitoring and/or organ support

 Any medical condition or disease with anticipation of deterioration

 Patients who have experienced any major intraoperative complication (e.g. cardiovascular or respiratory instability)

 Patients who have undergone major surgery, (e.g. thoracic, thoraco–abdominal, upper abdominal operations, trauma who require intensive monitoring or at a high risk of developing postoperative complications).

3. Patients who Should not be Admitted to the ICU:

Apart from clarifying the admission criteria for the ICUs, the new guidelines also clarified regarding the patients who cannot get admitted to the ICU. The details of patients who should not be admitted to ICU are as follows:

 Patient’s or next–of–kin informed refusal to be admitted in ICU

 Any disease with a treatment limitation plan

 Anyone with a living will or advanced directive against ICU care

 Terminally ill patients with a medical judgement of futility

 Low priority criteria in case of pandemic or disaster situation where there is resourcelimitation (e.g. bed, workforce, equipment).

4. ICU Discharge Criteria:

Along with the admission criteria, the Union Government has also specified the criteria for getting a discharge from the ICU. The following patients or the following situations can fulfill the ICU Discharge Criteria:

 Return of physiological aberrations to near normal or baseline status

 Reasonable resolution and stability of the acute illness that necessitated ICU admission

 Patient/family agrees for ICU discharge for a treatment-limiting decision or palliative care.

 Based on lack of benefit from aggressive care (should be a medical decision, not obligating family agreement and as far as possible should not be based on economic constraints).

 For infection control reasons with ensuring appropriate care of the given patient in a non ICU location

 Rationing (i.e., prioritisation in the face of a resource crunch). In this event there should be an explicit and transparent written rationing policy that should be fair, consistent and reasonable.

5. The Minimum patient monitoring required while awaiting an ICU bed: 

The Government has clearly mentioned in the guidelines regarding the minimum patient monitoring that is required while awaiting an ICU bed. These following factors should be monitored:

 Blood pressure (continuous/intermittent)

 Clinical monitoring (e.g., pulse rate, respiratory rate, breathing pattern, etc.)

 Heart rate (continuous/intermittent)

 Oxygen saturation – SpO2 (continuous/intermittent)

 Capillary refill time

 Urine Output (continuous/intermittent)

 Neurological status e.g. Glasgow Coma Scale (GCS), Alert Verbal Pain Unresponsive (AVPU) scale etc.

 Intermittent temperature monitoring

 Blood sugar

6. The Minimum stabilisation required before transferring a patient to ICU: 

As per the guidelines, the following aspects related to the stabilisation of a patient needs to be ensured before transferring a patient to the ICU:

 Ensuring a secure airway (i.e., tracheal intubation if the patient has a GCS ≤8)

 Ensuring adequate oxygenation and ventilation.

 Stable haemodynamics, either with or without vasoactive drug infusion.

 Ongoing correction of hyperglycemia/hypoglycemia and other life-threatening electrolyte/metabolic disturbances

 Initiation of definitive therapy for life-threatening condition (e.g., external fixation of a fractured limb, administration of antiepileptics for recurrent seizures, antiarrhythmic drug infusion for unstable arrhythmias etc, intravenous antibiotics for sepsis)

7. The Minimum monitoring required for transferring a critically ill patient (inter-facility transfer to hospital/ICU):

The guidelines also specified the minimum monitoring that is required to transfer a critically ill patient. As per the new guidelines, the following conditions should be monitored: 

 Blood pressure (continuous/intermittent)

 Clinical monitoring (pulse rate, respiratory rate, breathing pattern, etc.)

 Continuous Heart rate

 Continuous SpO2

 Neurological status (AVPU, GCS, etc.)

The Government guidelines for admission of patients to ICU have been issued more than 7 years after the Supreme Court took cognisance of the issue. Medical Dialogues had reported back in 2016 that taking into account the stream of medical negligence cases being filed against the medical professionals and hospital, the Supreme Court bench had asked the Central Government, and the erstwhile Medical Council of India (MCI), which has now been replaced by the National Medical Commission (NMC), to answer whether any guidelines are prescribed for private hospitals on providing care to patients in the Intensive Care Unit (ICU) and Critical Care Unit (CCU).

Also Read: Give guidelines on admission to ICU,CCU: SC to MCI, Centre

Powered by WPeMatico

Cow’s milk and donated breast milk equally effective and enriching in extremely preterm infants

Infants born extremely prematurely need to get enrichment as an addition to breast milk. But does it make any difference whether the enrichment is made from breast milk or cow’s milk when it comes to the risk of severe complications in children? This has been investigated by a large clinical study led from Linköping, Sweden.

Infants born extremely prematurely, between weeks 22 and 27 of pregnancy, are among the most vulnerable patients in healthcare. The risk of serious complications is very high. Almost one in four extremely premature babies die before the age of one.

There is strong research support for giving breast milk to these children rather than formula made from cow’s milk. It is known that cow’s milk-based formula increases their risk of getting, for example, severe intestinal inflammation and sepsis (severe blood-born infection).

“In Sweden, all extremely preterm infants receive breast milk from their mother or donated breast milk. Despite this, almost one in ten children get a severe inflammation of the intestine called necrotising enterocolitis. It’s one of the worst diseases you can have. At least three out of ten children die and those who survive often have neurological problems afterwards,” says Thomas Abrahamsson, professor at Linköping University and senior physician at the neonatal department at the University Hospital in Linköping, who led the current study.

Historically, there have been very few studies on extremely preterm infants where treatments have been compared against each other. Therefore, there is a great need for clinical studies that can provide scientific support for how these children should be treated to have better chances of survival and a good life.

In some countries, such as Sweden, infants are fed exclusively with either their mother’s breast milk or donated breast milk. However, in order for extremely preterm infants to grow as well as possible, they need more nutrition than breast milk contains. This is why breast milk is supplemented with extra protein, so-called enrichment.

The enrichment has previously been made from cow’s milk. But there have been suspicions that cow’s milk-based enrichment increases the risk of severe complications. Today, there is enrichment that is based on donated breast milk, and which has begun to be used in healthcare in some places. The big question is whether it can reduce the risk of diseases in extremely preterm infants.

The current study, called N-Forte (the Nordic study on human milk fortification in extremely preterm infants), is the largest that has been carried out to seek answers to this question. The results have been eagerly awaited by paediatricians and others caring for these fragile infants.

“We concluded that it doesn’t matter whether extremely preterm infants get enrichment made from cow’s milk or made from donated breast milk,” says Thomas Abrahamsson.

Although the study indicates that there was no difference between the two options, its results can be useful. The breast milk-based product is estimated to cost more than SEK 100,000 per child, which would be equivalent to around SEK 40 million if the product were to be used in Swedish healthcare.

“On the one hand, we’re disappointed that we didn’t find a positive effect of enrichment based on breast milk. On the other hand, it’s a large and well-done study and we can now say with great certainty that it doesn’t have an effect in this patient group. This is also important knowledge, so that we don’t invest in expensive products that don’t have the desired effect,” says Thomas Abrahamsson.

The N-Forte study included 228 extremely preterm infants, randomly divided into two equally-sized groups that received enrichment made from breast milk and cow’s milk respectively. The researchers examined whether the two groups differed in the incidence of necrotising enterocolitis, sepsis and death. Of the children treated with breast milk-based enrichment, 35.7% had these complications, while the corresponding proportion was 34.5% in the group receiving cow’s milk-based enrichment, which means that there was no difference betEClinicalMedicineween the groups.

The results of the study are in line with a smaller study from Canada published in 2018. In that study, the researchers also did not see any difference between the two types of enrichment on necrotising enterocolitis and severe sepsis.

The study was conducted at 24 neonatal departments in Sweden, with financial support from the Swedish Research Council, the Swedish Research Council in Southeast Sweden (FORSS), ALF funds and the company Prolacta Bioscience.

Reference:

Georg Bach Jensen, Magnus Domellöf, Fredrik Ahlsson, Anders Elfvin, Lars Navér, Thomas Abrahamsson,Effect of human milk-based fortification in extremely preterm infants fed exclusively with breast milk: a randomised controlled trial, DOI:https://doi.org/10.1016/j.eclinm.2023.102375.

Powered by WPeMatico

Guselkumab tied with early improvement in psoriasis associated arthritis

Guselkumab associated with early improvement of joints and reduced progression of psoriatic arthritis suggests a new study published in the Clinical Rheumatology.

Assess relationship between earlier clinical improvement and radiographic progression (RP) over 2 years in guselkumab-treated patients with active psoriatic arthritis (PsA).

Post hoc analyses combined data from DISCOVER-2 biologic-naïve adults with active PsA randomized to either guselkumab 100 mg every 4 weeks (Q4W) or guselkumab at W0, W4, then Q8W. Correlations (Spearman’s coefficient) between baseline disease parameters and total PsA-modified van der Heijde-Sharp (vdH-S) score were examined. Repeated-measures mixed models, adjusted for known RP risk factors, assessed the relationship between Disease Activity Index in PsA (DAPSA) improvement, DAPSA improvement exceeding the median or the minimal clinically important difference (MCID), or DAPSA low disease activity (LDA) at W8 and RP rate, assessed by change from baseline in vdH-S score through W100.

Results

Baseline age, PsA duration, CRP level, and swollen joint count, but not psoriasis duration/severity, weakly correlated with baseline vdH-S score. Elevated baseline CRP (parameter estimate [β] = 0.17–0.18, p < 0.03) and vdH-S score (β = 0.02, p < 0.0001) significantly associated with greater RP through W100. Greater improvement in DAPSA (β = -0.03, p = 0.0096), achievement of DAPSA improvement > median (least squares mean [LSM] difference: -0.66, p = 0.0405) or > MCID (-0.67, p = 0.0610), or DAPSA LDA (-1.44, p = 0.0151) by W8 with guselkumab significantly associated with less RP through W100. The effect of W8 DAPSA LDA on future RP was strengthened over time among achievers vs. non-achievers (LSM difference enhanced from -1.05 [p = 0.0267] at W52 to -1.84 [p = 0.0154] at W100).

In guselkumab-treated patients with active PsA, earlier improvement in joint symptoms significantly associated with lower RP rates through 2 years, indicating blockade of the IL-23 pathway may modify long-term disease course and prevent further joint damage.

Reference:

Mease, P.J., Gottlieb, A.B., Ogdie, A. et al. Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment. Clin Rheumatol (2023). https://doi.org/10.1007/s10067-023-06745-y

Keywords:

Guselkumab, associated, early, improvement, joints, reduced, progression ,psoriatic,arthritis, Mease, P.J., Gottlieb, A.B., Ogdie, Clinical Rheumatology

Powered by WPeMatico

Bariatric surgery may improve left ventricular structure, function and strain

Bariatric surgery may improve left ventricular structure, function and strain suggests a new study published in the Journal of the American Heart Association.

Obesity leads to an increased risk of cardiovascular disease morbidity and death, including heart failure. Bariatric surgery has been proven to be the most effective long‐term weight management treatment. This study investigated the changes in cardiac structure and function after bariatric surgery, including left ventricular global longitudinal strain. 398 consecutive patients underwent bariatric surgery with pre‐ and postoperative transthoracic echocardiographic imaging at a US health system between 2004 and 2019. We compared cardiovascular risk factors and echocardiographic parameters between baseline and follow‐up at least 6 months postoperatively. Along with decreases in weight postoperatively, there were significant improvements in cardiovascular risk factors, including a reduction in systolic blood pressure levels from 132 mm Hg to 127 mm Hg, glycated haemoglobin levels from 6.5% to 5.7%, and low‐density lipoprotein levels from 97 mg/dL to 86 mg/dL. Left ventricular mass decreased from 205 g to 190 g, left ventricular ejection fraction increased from 58% to 60%, and left ventricular global longitudinal strain improved from −15.7% to −18.6% postoperatively. This study has shown the long‐term impact of bariatric surgery on cardiac structure and function, with reductions in left ventricular mass and improvement in left ventricular global longitudinal strain. These findings support the cardiovascular benefits of bariatric surgery.

Reference:

Impact of Bariatric Surgery on Left Ventricular Structure and Function. Diarmaid Hughes, Ali Aminian, Chao Tu, Yuichiro Okushi, Yoshihito Saijo, Rickesha Wilson, Nicholas Chan, Ashwin Kumar, Richard A. Grimm, Brian P. Griffin, W. H. Wilson Tang, Steven E. Nissen and Bo Xu. Originally published29 Dec 2023https://doi.org/10.1161/JAHA.123.031505Journal of the American Heart Association. 2024;13:e031505

Keywords:

Bariatric, surgery, may, improve, left, ventricular, structure, function, and strain, Journal of the American Heart Association, Diarmaid Hughes, Ali Aminian, Chao Tu, Yuichiro Okushi, Yoshihito Saijo, Rickesha Wilson, Nicholas Chan, Ashwin Kumar, Richard A. Grimm, Brian P. Griffin, W. H. Wilson Tang, Steven E. Nissen and Bo Xu.

Powered by WPeMatico

Lung Cancer Risk High in Never-Smokers With Positive Family History: Lancet

The Taiwan Lung Cancer Screening in Never-Smoker Trial (TALENT) has revealed compelling insights into the prevalence and risk factors of lung cancer among non-smokers. The findings were published in the Lancet Respiratory Medicine.

The study was conducted across 17 medical centers in Taiwan and primarily focused on individuals aged 55 to 75 years who never smoked or had minimal smoking history along with additional risk factors for lung cancer. Lung cancers in Taiwan are disproportionately affecting never-smokers with nearly 60% diagnosed at a very advanced stage.

The study spanned over 8 years and included 12,011 participants, of which 6009 had a family history of lung cancer. LDCT scans at baseline identified 17.4% as positive, leading to the diagnosis of lung cancer in 2.6% of participants. Also, 77.4% of diagnosed cases were at stage I which highlighted the potential impact of early detection.

Participants with a family history of lung cancer demonstrated a higher prevalence of invasive lung cancer with increasing age. Factors such as female sex and age over 60 correlated with an increased risk of lung cancer. Importantly, passive smoke exposure and cooking-related variables showed no significant associations with lung cancer. The LDCT screening exhibited a high sensitivity of 92.1% and specificity of 84.6% that emphasize its effectiveness in early detection.

This study also acknowledges the potential for overdiagnosis, specially in cases of adenocarcinoma in situ. Further investigations into risk factors for lung cancer in non-smokers, especially those without a family history will be important to refine the screening protocols and improving outcomes in this vulnerable population. 

Reference:

Chang, G.-C., Chiu, C.-H., Yu, C.-J., Chang, Y.-C., Chang, Y.-H., Hsu, K.-H., Wu, Y.-C., Chen, C.-Y., Hsu, H.-H., Wu, M.-T., Yang, C.-T., Chong, I.-W., Lin, Y.-C., Hsia, T.-C., Lin, M.-C., Su, W.-C., Lin, C.-B., Lee, K.-Y., Wei, Y.-F., … Yang, S.-C. (2023). Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study. In The Lancet Respiratory Medicine. Elsevier BV. https://doi.org/10.1016/s2213-2600(23)00338-7

Powered by WPeMatico